Brand name
Unasyn, the original
We didn’t find a savings card or cash price from Unasyn’s maker. Ask the pharmacy for Unasyn’s cash price. With insurance, ask what your plan charges.
Generic name: ampicillin and sulbactam
Used for: Skin infections · Infections inside the belly · Gynecological infections · 2 more
Ask for the cash price
Generic ampicillin and sulbactam
No pharmacy we check posts a price for it.
A regular generic has the same active ingredient as Unasyn, and the FDA requires it to work the same way.
Unasyn, the original
We didn’t find a savings card or cash price from Unasyn’s maker. Ask the pharmacy for Unasyn’s cash price. With insurance, ask what your plan charges.
There isn’t one.
Same active ingredient as Unasyn. Fillers and dyes can differ.
9 companies sell a generic of Unasyn that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
It’s mostly filled by specialty pharmacies. Your prescriber’s office or insurer can tell you which one to use.
Made by Onesource Specialty Pharma
Product page on armaspharmaceuticals.com
1 g / 0.5 g Off-white
| Package | NDC |
|---|---|
| Carton of 10 | 72485-416-10 |
2 g / 1 g Off-white
| Package | NDC |
|---|---|
| Carton of 10 | 72485-417-10 |
10 g/15 g / 5 g/15 g White to off-white dry powder
| Package | NDC |
|---|---|
| Carton of 15 g | 72485-418-15 |
Made by Acs Dobfar Spa
1 g / 0.5 g
| Package | NDC |
|---|---|
| Carton of 10 | 83634-109-20 |
2 g / 1 g
| Package | NDC |
|---|---|
| Carton of 10 | 83634-110-20 |
10 g / 5 g
| Package | NDC |
|---|---|
| Carton of 1 | 83634-108-99 |
Made by Onesource Specialty Pharma
1 g / 0.5 g White to Off-white
| Package | NDC |
|---|---|
| Carton of 10 | 55150-116-20 |
1 g / 0.5 g White to Off-white
| Package | NDC |
|---|---|
| Carton of 10 | 55150-116-10 |
2 g / 1 g White to Off-white
| Package | NDC |
|---|---|
| Carton of 10 | 55150-117-20 |
2 g / 1 g White to Off-white
| Package | NDC |
|---|---|
| Carton of 10 | 55150-117-10 |
100 mg/mL / 50 mg/mL White to Off-white
| Package | NDC |
|---|---|
| Carton of 100 mL | 55150-118-99 |
100 mg/mL / 50 mg/mL White to Off-white
| Package | NDC |
|---|---|
| Carton of 100 mL | 55150-118-01 |
Made by Acs Dobfar Spa
1 g/1.5 g / 0.5 g/1.5 g
| Package | NDC |
|---|---|
| Carton of 15 g | 0641-6116-10 |
2 g/3 g / 1 g/3 g
| Package | NDC |
|---|---|
| Carton of 30 g | 0641-6117-10 |
100 mg/mL / 50 mg/mL
| Package | NDC |
|---|---|
| Vial of 100 mL | 0641-6118-01 |
Made by Acs Dobfar Spa
Product page on meithealpharma.com
1 g / 0.5 g
| Package | NDC |
|---|---|
| Carton of 10 | 71288-031-92 |
1 g / 0.5 g
| Package | NDC |
|---|---|
| Carton of 10 | 71288-031-21 |
2 g / 1 g
| Package | NDC |
|---|---|
| Carton of 10 | 71288-032-92 |
2 g / 1 g
| Package | NDC |
|---|---|
| Carton of 10 | 71288-032-21 |
10 g / 5 g
| Package | NDC |
|---|---|
| Carton of 1 | 71288-033-75 |
10 g / 5 g
| Package | NDC |
|---|---|
| Carton of 1 | 71288-033-91 |
Made by Acs Dobfar Spa
Product page on northstarrxllc.com
1 g / 0.5 g
| Package | NDC |
|---|---|
| Vial of 1 | 72603-220-01 |
| Carton of 10 | 72603-220-10 |
2 g / 1 g
| Package | NDC |
|---|---|
| Vial of 1 | 72603-335-01 |
| Carton of 10 | 72603-335-10 |
10 g / 5 g
| Package | NDC |
|---|---|
| Carton of 10 | 72603-444-01 |
Made by Acs Dobfar Spa and Antibiotice
1 g / 0.5 g
| Package | NDC |
|---|---|
| Carton of 10 | 25021-142-20 |
2 g / 1 g
| Package | NDC |
|---|---|
| Carton of 10 | 25021-143-30 |
100 mg/mL / 50 mg/mL
| Package | NDC |
|---|---|
| Carton of 100 mL | 25021-144-99 |
Made by Antibiotice and HQ Specialty Pharma
Product page on wgcriticalcare.com
1 g / 0.5 g
| Package | NDC |
|---|---|
| Carton of 10 | 44567-210-10 |
1 g / 2 g
| Package | NDC |
|---|---|
| Carton of 10 | 44567-150-10 |
1 g / 2 g
| Package | NDC |
|---|---|
| Carton of 10 | 44567-211-10 |
10 g / 5 g
| Package | NDC |
|---|---|
| Carton of 1 | 44567-212-01 |
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
“Before you fill my Unasyn, can you tell me what I’d pay for the brand and for a generic?”
Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.
UNASYN is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below.
Skin and Skin Structure Infections caused by beta-lactamase producing strains of Staphylococcus aureus, Escherichia coli, Efficacy for this organism in this organ system was studied in fewer than 10 infections. Klebsiella spp. (including K. pneumoniae ), Proteus mirabilis, Bacteroides fragilis, Enterobacter spp., and Acinetobacter calcoaceticus.
NOTE: For information on use in pediatric patients (see PRECAUTIONS–Pediatric Use and CLINICAL STUDIES sections).
Intra-Abdominal Infections caused by beta-lactamase producing strains of Escherichia coli, Klebsiella spp. (including K. pneumoniae ), Bacteroides spp. (including B. fragilis), and Enterobacter spp.
Gynecological Infections caused by beta-lactamase producing strains of Escherichia coli, and Bacteroides spp. (including B. fragilis ).
While UNASYN is indicated only for the conditions listed above, infections caused by ampicillin-susceptible organisms are also amenable to treatment with UNASYN due to its ampicillin content. Therefore, mixed infections caused by ampicillin-susceptible organisms and beta-lactamase producing organisms susceptible to UNASYN should not require the addition of another antibacterial.
Appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify the organisms causing infection and to determine their susceptibility to UNASYN.
Therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies when there is reason to believe the infection may involve any of the beta-lactamase producing organisms listed above in the indicated organ systems. Once the results are known, therapy should be adjusted if appropriate.
To reduce the development of drug-resistant bacteria and maintain effectiveness of UNASYN and other antibacterial drugs, UNASYN should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Source: the FDA label for Unasyn (Roerig), July 10, 2026. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/unasyn/